Clinical Trial Update: Allogeneic ABCB5-positive Stem Cells for Treatment of DFU "Malum Perforans" [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial update for allogeneic ABCB5-positive stem cells in diabetic neuropathic ulcers (DFU) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Neuropathic Ulcer

Drugs mentioned

• ABCB5-positive stem cells

Snippet

Sponsor: RHEACELL GmbH & Co. KG | Conditions: Diabetic Neuropathic Ulcer | Phase 1, Phase 2 | Status: COMPLETED